BEUDAMED
    FDA Adverse Event Injury Summary report: N

    COOLSCULPTING® SYSTEM

    MDR report key: 17201313 · Received June 26, 2023

    Report

    Report Number
    3007215625-2023-00935
    Event Type
    Injury
    Date Received
    June 26, 2023
    Date of Event
    May 15, 2023
    Report Date
    October 18, 2023
    Manufacturer
    ALLERGAN PLEASANTON
    Product Code
    OOK
    PMA / PMN Number
    K183514
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    FL, US
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    H11 - CORRECTED DATA: B5(AREA OF CONCERN).

    Additional Manufacturer Narrative · 0

    H11 - CORRECTED DATA: B5 (TREATMENT DATE, APPLICATOR), D1.

    Additional Manufacturer Narrative · 0

    THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING. ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PARADOXICAL ADIPOSE HYPERPLASIA (PH/PAH) IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PAH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE BECAUSE IT IS A RISK THAT IS INHERENT TO THE USE CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION. A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF AND WHEN ADDITIONAL INFORMATION IS OBTAINED.

    Description of Event or Problem · 0

    ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT TREATED THE UPPER, LOWER, AND MID ABDOMEN, INFRA-SCAPULAR, AND FLANKS ON (B)(6) 2023 AND (B)(6) 2023 WITH COOLSCULPTING COOLADVANTAGE COOLCURVE+, COOLADVANTAGE+, COOLCURVE+, COOLADVANTAGE PETITE AND COOLSCULPTING ELITE CURVE 120, CURVE 150, CURVE 240 HAS DEVELOPED PARADOXICAL HYPERPLASIA (PAH/PH). DIAGNOSED ON (B)(6) 2023 WITH PARADOXICAL ADIPOSE HYPERPLASIA (PAH) BY MEDICAL PROFESSIONAL.

    Description of Event or Problem · 0

    ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT TREATED THE MID ABDOMEN AND INFRA-SCAPULAR ON (B)(6) 2023 AND (B)(6) 2023 WITH COOLSCULPTING COOLADVANTAGE COOLCURVE+, COOLADVANTAGE+, COOLCURVE+, COOLADVANTAGE PETITE AND COOLSCULPTING ELITE CURVE 120, CURVE 150, CURVE 240 HAS DEVELOPED PARADOXICAL HYPERPLASIA (PAH/PH). DIAGNOSED ON (B)(6)2023 WITH PARADOXICAL ADIPOSE HYPERPLASIA (PAH) BY MEDICAL PROFESSIONAL.

    Description of Event or Problem · 0

    ALLERGAN AESTHETICS RECEIVED A REPORT OF A PATIENT TREATED THE MID ABDOMEN AND INFRA-SCAPULAR ON (B)(6) 2023 WITH COOLSCULPTING ELITE CURVE 120, CURVE 150, CURVE 240 HAS DEVELOPED PARADOXICAL HYPERPLASIA (PAH/PH). DIAGNOSED ON (B)(6) 2023 WITH PARADOXICAL ADIPOSE HYPERPLASIA (PAH) BY MEDICAL PROFESSIONAL.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    931289 COOLSCULPTING® SYSTEM DERMAL COOLING PACK/VACUUM/MASSAGER OOK ALLERGAN PLEASANTON NI

    Patients

    Seq Age Sex Outcome Treatment
    1 32 YR Female Required Intervention